Shannon M Young, OT | |
305 S State St, Aberdeen, SD 57401-4527 | |
(605) 622-5000 | |
(605) 622-5255 |
Full Name | Shannon M Young |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 305 S State St, Aberdeen, South Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003880402 | NPI | - | NPPES |
CG3429 | Other | ND | RAILROAD MEDICARE |
26336 | Other | ND | BLUE SHIELD |
50997 | Medicaid | ND |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 945 (North Dakota) | Secondary |
225X00000X | Occupational Therapist | 0286 (South Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Shannon M Young, OT Po Box 4400, Aberdeen, SD 57402-4400 Ph: (605) 622-5000 | Shannon M Young, OT 305 S State St, Aberdeen, SD 57401-4527 Ph: (605) 622-5000 |
News Archive
Cadence Health, the health system created through the merger of Central DuPage Health and Delnor Community Health System, announced an expansion of its relationship with the Cleveland Clinic to include cardiology services.
A new, free weekly ezine, Lab Animal e-Alert, helps scientists whose research involves lab animals assure regulatory and ethical compliance in their use. Its format is a reader question followed by an answer from an expert.
Subway may promote itself as the "healthy" fast food restaurant, but it might not be a much healthier alternative than McDonald's for adolescents, according to new UCLA research.
Mutations in a gene may cause poor lung development in children, making them more vulnerable to diseases such as chronic obstructive pulmonary disease (COPD) later in life, say researchers at the University of Pittsburgh Graduate School of Public Health and the German Research Center for Environmental Health.
Early findings by researchers at the University of Cincinnati College of Medicine suggest that the use of a second generation cancer drug, carfilzomib, may provide an improved approach for the reduction of antibodies in potential kidney transplant candidates.
› Verified 6 days ago